Vanguard Capital Management
LNAI

Vanguard Capital Management’s Lunai Bioworks LNAI Stock Holding History

Vanguard Capital Management’s Portfolio LNAI Stock Details LNAI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$52.6K Buy
16,081
+4,019
+33% +$11.1K ﹤0.01% 3932
2026
Q1 		$39.4K Buy
+12,062
New +$59.9K ﹤0.01% 3942

Other funds holding LNAI

GSC
Ground Swell Capital Folly Beach, South Carolina $92.6M AUM 41.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Vanguard Capital Management's LNAI Position: Q2 2026 in Review

Vanguard Capital Management increased its Lunai Bioworks (LNAI) stake by 33% in Q2 2026, buying an estimated $11.1K and bringing the position to 16,081 shares worth $52.6K. The position accounts for ﹤0.01% of the portfolio, ranked #3932.

Vanguard Capital Management first reported a position in LNAI in Q1 2026 and has held it in 2 quarters since. 15 funds tracked by Wall St. Rank hold LNAI as of Q2 2026.

  • Vanguard Capital Management held 16,081 shares of Lunai Bioworks worth $52.6K as of Q2 2026.
  • Vanguard Capital Management bought 4,019 Lunai Bioworks shares in Q2 2026, an estimated $11.1K.
  • Lunai Bioworks made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3932 holding.
  • Vanguard Capital Management first reported a position in Lunai Bioworks in Q1 2026 and has held it in 2 quarters since.
  • 15 funds tracked by Wall St. Rank held Lunai Bioworks as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.